EAM Investors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-40,625
| Closed | -$2.85M | – | 275 |
|
|
2024
Q1 | $2.85M | Sell |
40,625
-6,580
| -14% | -$461K | 0.44% | 124 |
|
|
2023
Q4 | $3.94M | Buy |
+47,205
| New | +$3.94M | 0.7% | 38 |
|
|
2022
Q4 | – | Sell |
-77,259
| Closed | -$3.74M | – | 282 |
|
|
2022
Q3 | $3.74M | Buy |
77,259
+6,457
| +9% | +$313K | 0.81% | 12 |
|
|
2022
Q2 | $2.78M | Buy |
70,802
+4,547
| +7% | +$179K | 0.68% | 25 |
|
|
2022
Q1 | $2.44M | Sell |
66,255
-41,743
| -39% | -$1.54M | 0.45% | 73 |
|
|
2021
Q4 | $4.92M | Sell |
107,998
-2,576
| -2% | -$117K | 0.81% | 10 |
|
|
2021
Q3 | $3.95M | Buy |
+110,574
| New | +$3.95M | 0.67% | 24 |
|
|
2020
Q4 | – | Sell |
-31,647
| Closed | -$685K | – | 315 |
|
|
2020
Q3 | $685K | Sell |
31,647
-93,531
| -75% | -$2.02M | 0.16% | 250 |
|
|
2020
Q2 | $2.95M | Buy |
+125,178
| New | +$2.95M | 0.65% | 28 |
|
|
2016
Q2 | – | Sell |
-306,003
| Closed | -$2.16M | – | 315 |
|
|
2016
Q1 | $2.16M | Sell |
306,003
-113,469
| -27% | -$800K | 0.34% | 145 |
|
|
2015
Q4 | $4.39M | Buy |
+419,472
| New | +$4.39M | 0.57% | 25 |
|
|
2013
Q3 | – | Sell |
-202,465
| Closed | -$2.34M | – | 328 |
|
|
2013
Q2 | $2.34M | Buy |
+202,465
| New | +$2.34M | 0.51% | 39 |
|